Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × budigalimab × 1 year × Clear all

Sponsor

Conditions

Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 5 Triple Negative Breast Neoplasms 3 Carcinoma, Hepatocellular 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Melanoma 1 Esophageal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Neuroendocrine 1 Anophthalmia with pulmonary hypoplasia 1

Interventions

pembrolizumab 16 Nivolumab 12 avelumab 8 Ipilimumab 6 Specimen Handling 5 Biopsy 5 atezolizumab 4 Magnetic Resonance Spectroscopy 4 cemiplimab 3 Cyclophosphamide 3 poly ICLC 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Radiotherapy 2 Radiosurgery 2 Interleukin-2 2 Immunoglobulin G 2 Docetaxel 2 Bevacizumab 2 tocilizumab 1 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 flt3 ligand protein 1 efineptakin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡